Medtronic plc (2M6.F)
| Previous close | 75.69 |
| Open | 76.70 |
| Bid | 76.75 x 100000 |
| Ask | 77.05 x 100000 |
| Day's range | 76.66 - 76.99 |
| 52-week range | 65.30 - 83.34 |
| Volume | |
| Avg. volume | 890 |
| Market cap | 104.015B |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | 26.28 |
| EPS (TTM) | 2.93 |
| Earnings date | 23 May 2024 |
| Forward dividend & yield | 2.57 (3.40%) |
| Ex-dividend date | 21 Mar 2024 |
| 1y target est | 145.56 |
ZacksHere's How Medtronic (MDT) Is Placed Ahead of Q4 Earnings
Medtronic's (MDT) rapid cadence of new product approvals is a strong foundation for future growth. However, the company also navigates some macroeconomic challenges.
GlobeNewswireMedtronic Recognized for Health Monitoring Innovation in 8th Annual MedTech Breakthrough Awards Program
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and CompaniesLOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market, today announced that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has been selected as winner of the “Best New Mo
PR NewswireMedtronic to announce financial results for its fourth quarter and full fiscal year 2024
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's fourth quarter and full fiscal year 2024, which ended on Friday, April 26, 2024.
